CrushSCI.com
Journal Selection & Manuscript Polishing Services
Current Molecular Pharmacology journal cover Biology
Back to journal directory

Review Cycle Records

Current Molecular Pharmacology

Elsevier SCIE Non-OA
2026 Emerging Zone 22025 CAS Zone 42025 JCR Q2
152.4Average days
173Median days
73Fastest days
195Longest days
402025 publications

Paper Review Records

All Paper Review Records

5 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

195 days

Integrative transcriptomic and metabolomic analyses of puerarin against cholestatic liver fibrosis

AuthorsDanhua Zhu; Qingmiao Shi; Xiaoxi Ouyang; Yanhong Zhang; Xiaopeng Yu; Long Yang; Kunkai Su; Lanjuan Li

AffiliationsState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, China-Singapore Belt and Road Joint Laboratory on Infection Research and Drug Development, National Medical Center for Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; Department of Infectious Diseases, The First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology, Luoyang, China; Yuhang Institute of Medical Science Innovation and Transformation, Hangzhou, China; Jinan Microecological Biomedicine Shandong Laboratory, Ji’nan, China

Source PDF DOI Publisher page
73 days

Metabolic reprogramming and epigenetic regulation: The dual role of lactate and lactylation in pancreatic ductal adenocarcinoma progression and therapeutics

AuthorsXiang Li; Wei Guo; Yihan Xie; Ryan Li; Wenxin Li; Han Wang; Ruixia Du; Hong Jiang; Yefu Liu; Zhe Liu

AffiliationsDepartment of Hepatobiliary and Pancreatic Surgery, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning 110042, China; Graduate School of China Medical University, China Medical University, Shenyang, Liaoning, China; Department of Otolaryngology, Central Hospital affiliated to Shenyang Medical College, Shenyang, Liaoning, China; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John’s University, Queens, New York 11439, USA

Source PDF DOI Publisher page
178 days

MiR-29a as a molecular target in cancer: Prevention strategies with natural products

AuthorsMuhanad Alhujaily

AffiliationsDepartment of Biochemistry, College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 11432, Saudi Arabia

Source PDF DOI Publisher page
143 days

Lactobacillus rhamnosus CMU-pb-7 alleviates diabetic nephropathy in a high-fat diet-streptozotocin rat model

AuthorsJie Jiang; Yuancheng Zhang; Cizhen Zheng; Shaobing Zhang; Yali Ding; Yanfang Liang; Juan Huang; Xingxing Chai; Bihua Lin; Jiahui Sun; Ziyu Ye; Biaowen Wei; Shaobo Wang; Qunfeng Yang; Jincheng Zeng

AffiliationsShenzhen University of Advanced Technology General Hospital, Shenzhen 518000, China; The Tenth Affiliated Hospital of Southern Medical University, Dongguan People's Hospital, Dongguan 523000, China; Dongguan Key Laboratory of Medical Bioactive Molecular Developmental and Translational Research, Guangdong Provincial Key Laboratory of Medical Immunology and Molecular Diagnostics, Guangdong Medical University, Dongguan 523808, China; Dongguan Proof-of-Concept Center for Medically Active Substances, Xianhua Medical Research Academy of Guangdong, Dongguan 523808, China; Houjie Hospital and Clinical College of Guangdong Medical University, Dongguan 523945, China; Department of Endocrinology, Binhaiwan Central Hospital of Dongguan, Dongguan 523000, China; Department of Internal Medicine, Liaobu Hospital, Dongguan 523000, China; Dongguan Key Laboratory of Molecular Immunopathology, Department of Pathology, Binhaiwan Central Hospital of Dongguan, Dongguan 523000, China; Hubei Province Wuhan Dongxihu District Maternal and Child Health Hospital, Wuhan 430040, China; Dongguan Hospital of Traditional Chinese Medicine, Dongguan 523000, China

Source PDF DOI Publisher page
173 days

IGFBP1 is a potential monitoring biomarker of disease activity in elderly patients with inflammatory bowel disease

AuthorsShuting Yang; Tingwang Jiang; Zhiliang Shi; Fang Zhou; Hongshuang Yu; Jiefang Huang; Xuefeng Li; Jian Guo; Hongmei Zhao; Qi Zhang; Bei Wang; Jieru Zhou; Yanyun Zhang; Guoqiang Zhou

AffiliationsDepartment of General Surgery, Changshu No. 2 Hospital, Gusu School, Nanjing Medical University, Jiangsu 215500, China; Department of Key Laboratory, The Affiliated Changshu Hospital of Nantong University, Jiangsu 215500, China; Department of Health Management, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200120, China; Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, Shanghai 200031, China

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.